Searched for
IMS MAT
Matt Ishbia set to acquire Phoenix Suns, Mercury basketball teams for record $4 billionMat Ishbia to buy Phoenix Suns and Phoenix Mercury from the owner Robert Sarver for $4 billion.- Sales of pharmacological sunscreens are surging. Here's whyAccording to the most recent data compiled by research firm IMS, prescription sunblock sales increased by over 55 percent in May over 2020.
- Lupin gets USFDA nod for generic contraceptive tabletsThe company has received final approval from the US Food and Drug Administration (USFDA) to market Tydemy, which is a generic version of Ba...
- Lupin gets USFDA nod to market generic anti-bacterial drugThe company has received final approval from the US Food and Drug Administration (US FDA) to market metronidazole tablets in strengths of 2...
- Lupin launches generic hypertension drug in US marketThe Mumbai-based company's product is the generic equivalent of Daiichi Sankyo Inc's Benicar tablets which is indicated for the treatment o...
- Lupin receives US FDA approval for anti-inflammatory topical solutionFluocinonide topical solution USP, 0.05% clocked sales of $32.4 million in the US, Lupin said in a release citing IMS MAT March 2017 data.
- Lupin launches cream in US to treat skin inflammationAs per IMS MAT December 2016 data "Temovate clobetasol propionate scalp application had US sales of $64.1 million", Lupin said.
- Lupin gets final USFDA nod for Mylan's skin disease creamThe approval is for multiple strengths of 0.025 per cent, 0.1 per cent and 0.5 per cent triamcinolone acetonide cream, said the company.
- Lupin gets USFDA nod for cevimeline hydrochloride capsulesThe company's product is a generic version of Daiichi Sankyo Inc's Evoxac capsules, it added.
- Lupin gets USFDA nod for pitavastatinThe firm has received tentative approval from United States Food and Drug Administration to market its Pitavastatin tablets in the strength...
- Lupin gets USFDA nod for generic pain relieving drugAs per IMS MAT sales data, Hydrocodone Bitartrate and Acetaminophen tablets had sales of USD 89.6 million in the US market.
- Lupin launches Amabelz tablets in US marketThe company's product is indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and pre...
- Lupin arm gets tentative FDA nod for anti-bacterial drugGavis has received tentative approval for its Azithromycin for oral suspension USP from the USFDA, Lupin said in a BSE filing.
- 21-year-old Jamshedpur girl gets perfect 800 in MATShalu Munka has a bachelor’s degree in business administration and managed a perfect score in the management aptitude test.
- Lupin gets FDA nod for generic Aricept tabletsLupin said it has received final approval from the US drug regulator to market generic Aricept tablets used for treatment of dementia.
- Lupin launches generic Niaspan tablets in US marketThe company's US subsidiary, Lupin Pharmaceuticals Inc has launched the generic Niaspan tablets in multiple strengths of 500mg, 750 mg & 10...
- Lupin launches generic Fenofibric Acid capsules in US marketLupin said its US arm has launched generic Fenofibric Acid capsules used for reducing cholesterol and fatty acids in the blood in the Ameri...
- US turnaround will revive indian IT's fortunes: Jyotivardhan Jaipuria, MD, Bank of America-Merrill LynchWith the US GDP forecast to grow at 2.5-3%, companies are seeing strong demand and high visibility on order inflows.
- Indian pharmaceutical market is over Rs 55,000 crIndian pharmaceutical market, which has registered robust growth in last few years, was valued at over Rs 55,000 crore in the last fiscal, ...
- Ranbaxy to market Lisinopril tablets in CanadaRanbaxy Laboratories has got approval from Health Canada, Therapeutic Products Directorate to manufacture and market Lisinopril 5, 10 and 2...
Load More
